Anaemia In CKD-Optimum Management and Overcoming Challenges

Anaemia in chronic kidney disease (CKD) is common, multifactorial, and linked to poorer clinical outcomes and diminished quality of life. Effective care requires systematic evaluation (including iron status and inflammation), individualized targets, and judicious use of therapies such as iron supplementation and erythropoiesis-stimulating agents (ESAs). This highly interactive webinar will translate evidence and guideline principles into practical steps for everyday practice, with real-world cases, decision pathways, and a focused discussion on managing renal anaemia using Epoetin Beta (Recormon®) and methoxy polyethylene glycol-epoetin beta  (Mircera®) within current standards of care.

WHY YOU SHOULD ATTEND

1. Gain a clear, stepwise framework for evaluating and treating CKD-related anaemia.

2. Refresh and update your understanding of iron optimization and ESA stewardship.

3. Learn pragmatic strategies to overcome common challenges (inflammation, ESA hyporesponsiveness, comorbid cardiovascular risk, and resource constraints).

4. Engage directly with an experienced faculty member through case discussions, polls, and an extended Q&A.

5. Leave with practical tools—checklists, dosing/monitoring prompts, and follow-up cues—you can apply immediately.

6. Earn CPD credit (via Council) for verifiable professional development.

EVENT HIGHLIGHTS

i. Impact of Anaemia in CKD: Burden, consequences, and quality-of-life impact.

ii. Approach to Management: A structured algorithm from screening to long-term follow-up.

iii. Evaluation, Treatment, Targets: Interpreting Hb, ferritin, TSAT; setting realistic targets; timing of interventions.

iv. ESAs in Practice: Initiation, maintenance, monitoring, safety/precautions, and addressing hyporesponsiveness.

v. Overcoming Challenges: Inflammation, infection, iron deficiency, adherence, and cardiovascular considerations.

vi. Focused Therapeutics Session: Management of renal anaemia using Recormon® and Mircera® in line with contemporary practice.

vii. Interactive Learning: Audience polling, case vignettes, and extended Q&A.

TOPICS AND RELEVANT AREAS TO BE PRESENTED

1. Impact of Anaemia in CKD: Epidemiology, pathophysiology, outcomes, and patient-centred measures.

2. Approach to Management: Workflow for primary and specialist settings; role delineation; follow-up intervals.

3. Evaluation, Treatment, Targets: Workup (Hb trend, iron indices, CRP/inflammation), iron strategies (oral vs IV), target setting.

4. ESAs—Initiation, Maintenance, Precautions: Selection, dose titration, monitoring, risk mitigation (e.g., hypertension, thromboembolic risk).

5. Challenges in Management: ESA hyporesponsiveness, functional iron deficiency, intercurrent illness, adherence, and resource limitations.

6. Anaemia in CKD—Optimum Management & Overcoming Challenges: Integrating evaluation, iron therapy, and ESA use into a coherent pathway.

7. Management Using Modern Therapy Options: Positioning, practical pearls, and real-world case applications within guideline-consistent care.

PARTICIPANT CONSENT AND DATA PRIVACY NOTICE

By registering for “Anaemia in CKD—Optimum Management and Overcoming Challenges,” you consent to participate in this training hosted by CES on behalf of Roche. Your registration will provide us with the necessary information to facilitate the event and issue CPD accreditation through the Medical and Dental Council (MDC). Please note that CES is committed to safeguarding your personal information and will not share any personal data with Roche. Your data will only be shared with the relevant regulatory bodies, such as MDC, PC for the sole purpose of accrediting you with CPD points earned through this training.

Additionally, participants are free to opt out of the meeting at any time, and should you wish to do so, no further action is required on your part. We respect your privacy and ensure that your participation will be treated with the highest level of confidentiality.

PROUDLY SPONSORED BY

This is a virtual event scheduled for Wednesday, the 20th of August, 2025 at 16:00 GMT.  

Moderator: Prof. Elliot Tannor

Senior Lecturer, Department of Medicine, Kwame Nkrumah University of Science and Technology || Senior Specialist Physician and Nephrologist, Komfo Anokye Teaching Hospital

Date: Wednesday, 20th August, 2025

Time: 16:00 GMT (4:00 PM Local Time)

AGENDA